Neuromuscular Biology & Disease Groupat the Boston University School of Medicine
Our goals are to identify pathogenetic mechanisms and to develop new therapeutic strategies for neuromuscular diseases.
January 3rd, 2011
Dr. James Windelborn has joined our group from the University of Wisconsin.